Follow the cases of 2 patients who developed immune-related adverse events following treatment with immune checkpoint blockade.
This activity is intended for oncologists, emergency medicine physicians, pulmonologists, and nurses.
The goal of this activity is to review strategies for identifying and managing adverse events associated with treatment with immune checkpoint blockade.
Approximate Time to Complete: 30 minutes
Credit Available: Feb. 28, 2018 - Feb. 28, 2019
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Counsel patients on how to communicate with clinicians if they suspect an immune-related adverse effect may be caused by ongoing treatment with an immune checkpoint inhibitor
- Identify appropriate treatment strategies to manage immune-related adverse events associated with immune checkpoint inhibitors
- Identify the symptoms of immune-related adverse effects